Literature DB >> 15723147

[Early diagnosis of colorectal tumors].

C Lamberti1, T Sauerbruch.   

Abstract

Colorectal cancer (CRC) is one of the most common causes of cancer mortality in Western countries. Approximately six percent of the population will develop colorectal cancer during life. Individuals older than 50 years or with a family history for colorectal tumors as well as patients with an inflammatory bowel disease have an increased risk for CRC. A significant reduction of colorectal cancer mortality can be achieved by screening of asymptomatic patients and removal of premalignant adenomatous polyp precursors. Colonoscopy is recognized as the gold standard, but in future virtual colonoscopy might be a reasonable addition. Asymptomatic individuals with an average risk for CRC should be screened from the age of 50 and then every 10 years if the examination showed no pathological findings. When the individual or family history indicate a higher risk for a colorectal neoplasia, screening should begin at the age of 40 or 10 years before the earliest tumor occurrence in the family. Families with hereditary CRC require a special surveillance.

Entities:  

Mesh:

Year:  2005        PMID: 15723147     DOI: 10.1007/s00108-005-1369-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  43 in total

1.  Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults.

Authors:  Perry J Pickhardt; J Richard Choi; Inku Hwang; James A Butler; Michael L Puckett; Hans A Hildebrandt; Roy K Wong; Pamela A Nugent; Pauline A Mysliwiec; William R Schindler
Journal:  N Engl J Med       Date:  2003-12-01       Impact factor: 91.245

2.  Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists.

Authors:  A Sieg; U Hachmoeller-Eisenbach; T Eisenbach
Journal:  Gastrointest Endosc       Date:  2001-05       Impact factor: 9.427

3.  Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089.

Authors:  Robert J Green; Joshua P Metlay; Kathleen Propert; Paul J Catalano; John S Macdonald; Robert J Mayer; Daniel G Haller
Journal:  Ann Intern Med       Date:  2002-02-19       Impact factor: 25.391

4.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.

Authors:  B Levin; K Hess; C Johnson
Journal:  Arch Intern Med       Date:  1997-05-12

Review 6.  Gastrointestinal polyposis syndromes.

Authors:  Mary P Bronner
Journal:  Am J Med Genet A       Date:  2003-11-01       Impact factor: 2.802

7.  Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps.

Authors:  A Liljegren; A Lindblom; S Rotstein; B Nilsson; C Rubio; E Jaramillo
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

8.  New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy.

Authors:  Benjamin Avidan; Amnon Sonnenberg; Thomas G Schnell; Jack Leya; Adrienne Metz; Stephen J Sontag
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

9.  The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval.

Authors:  V Paul Doria-Rose; Theodore R Levin; Joe V Selby; Polly A Newcomb; Kathryn E Richert-Boe; Noel S Weiss
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

10.  Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo.

Authors:  Ralf Kiesslich; Juergen Burg; Michael Vieth; Janina Gnaendiger; Meike Enders; Peter Delaney; Adrian Polglase; Wendy McLaren; Daniela Janell; Steven Thomas; Bernhard Nafe; Peter R Galle; Markus F Neurath
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

View more
  2 in total

Review 1.  A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancer.

Authors:  Mallikarjuna Uppara; Franklin Adaba; Alan Askari; Susan Clark; George Hanna; Thanos Athanasiou; Omar Faiz
Journal:  World J Surg Oncol       Date:  2015-02-13       Impact factor: 2.754

2.  Expression of tumor pyruvate kinase M2 isoform in plasma and stool of patients with colorectal cancer or adenomatous polyps.

Authors:  Farideh Rigi; Aliakbar Jannatabad; Azra Izanloo; Reza Roshanravan; Hamid Reza Hashemian; Mohammad Amin Kerachian
Journal:  BMC Gastroenterol       Date:  2020-07-29       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.